Brazil

What is newsworthy about ivermectin? A simple Google search of most drugs describes the uses and side effects of the searched medication.
However, a similar search for ivermectin provides headlines for why it should not be taken for Covid-19 and how dangerous it is.TheGuardian describes ivermectin as a horse drug and reminds readers, considering taking medicine, and echoing a post by the FDA, Youre not a horse.
Youre not a cow, saying it is a drug intended for farm animals.
TheFDA echoedthat sentiment in a recent tweet.The BBC writes: Ivermectin: How fake science created a covid miracle drug, while the Washington Post explains: What is ivermectin, and how did people get the idea it could treat Covid?The Business Insider aims at the largest Latin American country: Brazils tragic ivermectin frenzy is a warning for the United States , experts say.CNN affirms: Comprehensive mess: CNN examines dubious story on deworming drug, and the British Daily Mail writes this: Ivermectin should NOT be given to NHS Covid patients because it makes no difference to their illness and may even make them worse, new guidance says.With so many mighty media giants taking a dismissive and sometimes even aggressive stance against this medication, we at The Rio Times thought that some Ivermectin history couldnt hurt and would maybe provide a different perspective.
Watch the video above.Join us on Telegram:t.me/theriotimes





Unlimited Portal Access + Monthly Magazine - 12 issues


Contribute US to Start Broadcasting - It's Voluntary!


ADVERTISE


Merchandise (Peace Series)

 


Mexican Peso Maintains Six-Month High as Mexico Navigates Economic Crosscurrents


Brazilian Authorities Uncover $1.1 Billion Pension Fraud Targeting Millions


Iron Ore Slips Below $100 Mark as China Demand Concerns Persist


Silver Navigates Trade Tensions and Supply Deficit as Prices Edge Upward


Copper Market Rebounds Amid Trade Optimism Despite Global Economic Concerns


Crude Rebounds: Brent and WTI Rally from Multi-Month Lows as May Trading Begins


Gold Rebounds from Two-Week Low as Trade Tensions Ease and Market Eyes Jobs Data


Bitcoin Climbs as Altcoins Diverge, ETF Hopes and Policy Moves Shape Crypto Market


Ibovespa Holds Steady as Global Volatility and Local Fundamentals Collide


Santander Brasil Posts Strong Q1 Profit, Underlines Strategic Value for Parent Group


Eurozone Growth Outpaces Forecasts but Faces Trade Headwinds


Uncertainty Over Peso Drives Argentine Soybean Sales to Decade Lows


Peru’s Largest Bank Tests Bitcoin Trading, Eyes New Payment Solutions


WEG’s First Quarter: Growth Outpaces Peers, But Margins Face Pressure


Ukraine and U.S. Forge Rare Earths Pact to Counter China's Supply Chain Grip


U.S. Pending Home Sales Surge on Lower Mortgage Rates, Inventory Rises


Import Surge Ahead of Tariffs Drives U.S. GDP Down in Early 2025


High Earners Flee New York: $9 Billion Income Shift to Conservative Florida


German Inflation Slows, but Service Sector Costs Remain Stubbornly High